AbbVie

Featured Drug Company Program

AbbVie, together with Genentech, has developed and is marketing the oncology drug Venclexta (venetoclax), which was approved by the FDA in April 2016. Venclexta is indicated for patients with chronic lymphocytic leukemia with deletion 17p who have received at least [ Read More ]

American Regent

Featured Drug Company Program

American Regent offers comprehensive reimbursement services and patient support to providers and patients. American Regent’s IV Iron Patient Assistance Program facilitates access to Injectafer (ferric carboxymaltose injection) for patients who are prescribed the treatment but are unable to afford it [ Read More ]

Amgen

Featured Drug Company Program

Amgen Assist 360 provides several support options for insured, uninsured, and underinsured patients who encounter financial hardships and cannot afford the Amgen medications they are prescribed. Because individual copay foundations have their own eligibility criteria and application process, Amgen urges [ Read More ]

ARIAD

Featured Drug Company Program

ARIAD’s Patient Access & Support Services program (ARIAD PASS) is a comprehensive support program that provides coverage and reimbursement support, as well as financial assistance for patients who have been prescribed Iclusig (ponatinib) and are unable to afford their medication. [ Read More ]

Astellas

Featured Drug Company Program

Astellas Pharma’s Xtandi Support Solutions program offers patient assistance services to eligible patients who are prescribed Xtandi (enza­lutamide) for metastatic castration-­resistant prostate cancer (Table). Table Astellas Oncology Drugs Drug Indications Patient support programs Contact information Xtandi(enzalutamide) Metastatic, castration-resistant prostate cancer [ Read More ]

AstraZeneca

Featured Drug Company Program

AstraZeneca offers several patient assistance programs to help patients access and afford AstraZeneca medicines (Table). AstraZeneca also has a field-based team of Field Reimbursement Managers who can visit your office to provide information regarding how to access Astra­Zeneca medicines. To [ Read More ]

Bayer

Featured Drug Company Program

Bayer HealthCare offers comprehensive support services for eligible patients who are prescribed their Bayer oncology drugs through several patient support programs, including its Oncology $0 Co-Pay Program, the REACH (Resources for Expert Assistance and Care Helpline) program, and the Xofigo [ Read More ]

Boehringer Ingelheim

Featured Drug Company Program

Boehringer Ingelheim (BI)’s Solutions Plus offers a variety of support programs to patients prescribed Gilotrif (afatinib) who require financial assistance (Table). Table Boehringer Ingelheim Oncology Drugs Drug Indications Patient support programs Contact information Gilotrif(afatinib) Metastatic NSCLC with EGFR mutation; metastatic [ Read More ]

Bristol-Myers Squibb

Featured Drug Company Program

Through its Access Support program, Bristol-Myers Squibb (BMS) offers a variety of oncology support options for patients receiving outpatient treatment in the United States and Puerto Rico, and, in certain circumstances, the Virgin Islands. The BMS Access Support program offers [ Read More ]